The mortality from malignant neoplasms in U.S. females shows a gradual increase from 2024 to 2028, starting at 286.42 thousand deaths in 2024 and reaching 288.21 thousand by 2028. Considering 2023 as the baseline, this data suggests a steady upward trend in mortality, reflecting an annual growth of about 0.20% year-on-year. Cumulatively over the five-year period, the compound annual growth rate (CAGR) is approximately 0.20%.
Future trends to watch include potential shifts in healthcare policies, advancements in cancer treatment and early detection, and changes in public health initiatives, which could significantly impact these projected mortality figures.
